For decades, the breast cancer screening conversation has started around age 40. New guidance from the American College of Radiology® (ACR®) moves that conversation forward by 15 years, urging all women to undergo a formal breast cancer risk assessment by age 25. The recommendation, detailed in ACR's recommendations, signals a fundamental shift from a one-size-fits-all screening model to one based on individual risk.
The change matters because breast cancer remains one of the most commonly diagnosed cancers in the United States, and early detection is among the most effective tools for improving outcomes. Widespread screening has already contributed to a significant decline in breast cancer mortality by catching the disease earlier, when treatment is most effective. Yet the current age-based approach misses a critical reality: risk is not uniform. Factors such as family history, genetic mutations, and other health considerations can substantially increase a person's likelihood of developing breast cancer, potentially warranting earlier or supplemental screening.
The ACR's guidance places particular emphasis on Black women and women of Ashkenazi Jewish descent, who may face elevated risk factors or worse breast cancer outcomes. Data show that among Asian, Black, and Hispanic women, one-third of all breast cancers are diagnosed before age 50. That statistic alone underscores why relying solely on age 40 as a starting point can leave younger, higher-risk individuals undiagnosed until later stages. A risk assessment by age 25 creates an opportunity to identify those individuals and build a personalized screening strategy before cancer develops.
"Breast cancer screening is not a one-size-fits-all approach," said Stamatia Destounis, MD, FACR, chair of the American College of Radiology Breast Imaging Commission. "A risk assessment by age 25 can help identify those who may benefit from earlier screening or supplemental imaging. Understanding your personal risk allows people and their healthcare providers to make informed decisions based on their unique circumstances."
The recommendation also extends to transgender individuals, for whom breast cancer risk can be influenced by anatomy, hormone use, family history, genetics, and prior medical care. Healthcare providers can use these factors to develop individualized screening recommendations that reflect each person's specific risk profile and health history. This inclusive approach reflects a broader understanding that breast cancer risk is shaped by a complex mix of biological and clinical factors, not simply by age or gender identity.
For patients wondering how to begin, resources are available. Mammography Saves Lives, an educational initiative of ACR, provides information about breast cancer risk factors, breast density, screening recommendations, and questions patients can discuss with their healthcare providers. The initiative aims to make the risk assessment process more accessible and to encourage proactive conversations between patients and clinicians.
Breast Cancer Awareness Month serves as a recurring reminder of the importance of early detection, but the implications of this guidance extend well beyond a single month. By moving risk assessment to age 25, the ACR is advocating for a healthcare paradigm in which screening decisions are driven by personal risk rather than arbitrary age thresholds. For some women, that shift could mean earlier detection and more effective treatment. For others, it could mean a clearer understanding of their own risk and a more informed dialogue with their doctors. In a disease where one in eight women will receive a diagnosis in their lifetime, starting the conversation earlier is not just a clinical recommendation; it is a potentially life-saving change in how breast health is managed from young adulthood onward.
